Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study to Test the Immunogenicity of Variant Schedules for TBE Rapid Immunisation Using Inactivated TBE (FSME) Vaccine

NCT00890422 is registered in ClinicalTrials.gov with Elisabethinen Hospital as lead sponsor.

NCT NCT00890422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00890422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study to Test the Immunogenicity of Variant Schedules for TBE Rapid Immunisation Using Inactivated TBE (FSME) Vaccine
Lead sponsor
Elisabethinen Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2007
Completion date
July 31, 2010
Enrollment
99 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tick borne encephalitis